Search - tctmd.com

Displaying 21 - 40 of 136

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

Caitlin E. Cox

June 03, 2020

News Daily News

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

Michael O'Riordan

January 27, 2020

News Daily News

Diabetes Does Not Appear to Hinder FFR Insights for CAD

Caitlin E. Cox

January 09, 2020

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Daily News

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Caitlin E. Cox

October 24, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News SCAI 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Yael L. Maxwell

June 04, 2019

Presentation iTOP 2019

Caso clínico: Varón 41 años. HTA y dislipemia sin tratamiento, obesidad IMC

Presenter: Rosa Alba Abellás Sequeiros

June 04, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

Presentation OPCI 2019

Physiologic Lesion Assessment Can Be Misleading And Is Not Practical In Every Case

Presenter: Richard Shlofmitz

March 09, 2019

News Features

Top News in Imaging: 2018

Caitlin E. Cox

December 28, 2018

News Daily News

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

Todd Neale

September 21, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News ACC 2018

iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis

Caitlin E. Cox

March 10, 2018

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Todd Neale

February 21, 2018

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Advertisement

TCTMD’s Top 10 Most Popular Stories for August 2020

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

Diabetes Does Not Appear to Hinder FFR Insights for CAD

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Caso clínico: Varón 41 años. HTA y dislipemia sin tratamiento, obesidad IMC

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Physiologic Lesion Assessment Can Be Misleading And Is Not Practical In Every Case

Top News in Imaging: 2018

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content